Ellevest, Inc. Astrazeneca PLC Transaction History

Ellevest, Inc.

$608 Million
Q2 2025

A detailed history of Ellevest, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Ellevest, Inc. holds 8,816 shares of AZN stock, worth $725,909. This represents 0.1% of its overall portfolio holdings.

Number of Shares

8,816

Previous 9,524 7.43%

Holding current value

$725,909

Previous $700,000 12.0%

% of portfolio

0.1%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$64.87 - $75.0 $45,927 - $53,100	-708 Reduced 7.43%	8,816 $616,000
Q1 2025 May 14, 2025	SELL	$65.37 - $77.96 $429,415 - $512,119	-6,569 Reduced 40.82%	9,524 $700,000
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $321,056 - $404,266	-5,080 Reduced 23.99%	16,093 $1.05 Million
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $66,932 - $76,492	-873 Reduced 3.96%	21,173 $1.65 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $290,222 - $351,125	4,344 Added 24.54%	22,046 $1.72 Million
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $112,417 - $128,147	1,842 Added 11.61%	17,702 $1.2 Million
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $32,739 - $36,649	-529 Reduced 3.23%	15,860 $1.07 Million
Q3 2023 Nov 09, 2023	BUY	$64.85 - $71.7 $87,612 - $96,866	1,351 Added 8.98%	16,389 $1.11 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $19,994 - $21,681	286 Added 1.94%	15,038 $1.08 Million
Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $25,260 - $28,639	400 Added 2.79%	14,752 $1.02 Million
Q4 2022 Feb 03, 2023	BUY	$54.21 - $70.44 $120,942 - $157,151	2,231 Added 18.41%	14,352 $973,000
Q3 2022 Nov 02, 2022	SELL	$53.02 - $135.75 $168,073 - $430,327	-3,170 Reduced 20.73%	12,121 $665,000
Q2 2022 Jul 18, 2022	BUY	$59.26 - $71.14 $72,889 - $87,502	1,230 Added 8.75%	15,291 $1.01 Million
Q1 2022 Apr 19, 2022	BUY	$55.72 - $67.12 $201,427 - $242,638	3,615 Added 34.61%	14,061 $933,000
Q4 2021 Jan 24, 2022	SELL	$54.02 - $63.83 $41,865 - $49,468	-775 Reduced 6.91%	10,446 $608,000
Q3 2021 Oct 19, 2021	BUY	$55.56 - $60.79 $133,344 - $145,896	2,400 Added 27.21%	11,221 $674,000
Q2 2021 Jul 13, 2021	BUY	$48.42 - $60.18 $110,397 - $137,210	2,280 Added 34.86%	8,821 $528,000
Q1 2021 May 03, 2021	BUY	$47.16 - $54.44 $50,083 - $57,815	1,062 Added 19.38%	6,541 $325,000
Q4 2020 Feb 04, 2021	BUY	$48.52 - $58.02 $54,148 - $64,750	1,116 Added 25.58%	5,479 $274,000
Q3 2020 Oct 26, 2020	BUY	$53.07 - $61.1 $45,693 - $52,607	861 Added 24.59%	4,363 $239,000
Q2 2020 Jul 06, 2020	BUY	$43.1 - $55.31 $57,064 - $73,230	1,324 Added 60.79%	3,502 $185,000
Q1 2020 Apr 13, 2020	BUY	$37.79 - $51.33 $40,208 - $54,615	1,064 Added 95.51%	2,178 $97,000
Q4 2019 Feb 05, 2020	BUY	$42.46 - $50.46 $36,727 - $43,647	865 Added 347.39%	1,114 $56,000
Q3 2019 Oct 08, 2019	BUY	$40.12 - $45.47 $521 - $591	13 Added 5.51%	249 $11,000
Q2 2019 Aug 20, 2019	BUY	$37.28 - $41.68 $8,798 - $9,836	236 New	236 $10,000

Others Institutions Holding AZN

# of Institutions

1,451

Shares Held

489M

Call Options Held

7.22M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $255B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account